Gheyath K Nasrallah
Overview
Explore the profile of Gheyath K Nasrallah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
191
Citations
5641
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chemaitelly H, Ayoub H, Faust J, Coyle P, Tang P, Hasan M, et al.
BMJ Public Health
. 2025 Feb;
1(1):e000479.
PMID: 40017867
Objective: To assess the evolution of COVID-19 severity and fatality in a unique setting that consistently applied, throughout the pandemic, rigorous and standardised criteria for defining severe COVID-19 outcomes. Methods...
2.
Chemaitelly H, Ayoub H, Coyle P, Tang P, Hasan M, Yassine H, et al.
Nature
. 2025 Feb;
PMID: 39910292
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved over short timescales, leading to the emergence of more transmissible variants such as Alpha and Delta. The arrival of...
3.
Nasrallah G, Younes S, Younes N, Nizamuddin P, Alabdulmalek M, Mohammad K, et al.
IJID Reg
. 2025 Jan;
14:100561.
PMID: 39877413
Objectives: The chemiluminescence immunoassay automated Abbott ARCHITECT hepatitis B surface antigen (HBsAg) screening assay is globally recognized for its superior sensitivity but notably low specificity. This mandates positive results confirmation...
4.
Krishnamurthy H, Jayaraman V, Krishna K, Wang T, Bei K, Changalath C, et al.
Sci Rep
. 2025 Jan;
15(1):2527.
PMID: 39833196
Tick-borne infections are the most common vector-borne diseases in the USA. Ticks harbor and transmit several infections with Lyme disease being the most common tickborne infection in the US and...
5.
Razzaq A, Elkahlout R, Nasrallah G, Ibrahim F, Samara M, Zayed H, et al.
Lifestyle Genom
. 2025 Jan;
:1-23.
PMID: 39746347
Introduction: Preterm birth (PTB) is associated with newborn morbidity and mortality. DNA methylation plays an important role in the development of fetus, thus can also serve as an epigenetic biomarker....
6.
Prevalence of syphilis infection among migrant workers in Qatar: a nationwide cross-sectional survey
Nasrallah G, Chemaitelly H, Ismail A, Al-Sadeq D, Amanullah F, Al-Emadi J, et al.
BMJ Open
. 2024 Nov;
14(11):e083810.
PMID: 39609019
Objectives: Scant data are available on syphilis infection within migrant populations worldwide and in the population of the Middle East and North Africa region. This study investigated the prevalence of...
7.
Zedan H, Elkhider A, Hicazi A, Amanullah F, Al-Sadeq D, Nizamuddin P, et al.
J Infect Public Health
. 2024 Nov;
17(12):102590.
PMID: 39549536
Background: Human herpesvirus 8 (HHV-8) is a critical causative agent behind Kaposi sarcoma (KS), an oncogenic disease with profound consequences in immunocompromised individuals. Studies suggested HHV-8 seroprevalence in healthy populations...
8.
Nasrallah G, Younes N, Khalid H, Al-Emadi J, Younes S, Abouassali M, et al.
Sci Rep
. 2024 Nov;
14(1):28177.
PMID: 39548153
Architect-HIV Ag/Ab combo chemiluminescence assay is globally recognized for its sensitivity but has a notable false-positive rate. In this study, we aim to evaluate the performance of a new cost-effective...
9.
Cai W, Wang M, Hadad A, Zhang Y, Tran S, Shurbaji S, et al.
Front Bioeng Biotechnol
. 2024 Nov;
12:1425450.
PMID: 39493305
Objectives: The aim of this study was to investigate the impact of electrochemical treatment of a titanium surface employing constant current and potential on the viability of the tissue cells...
10.
Chemaitelly H, Ayoub H, Coyle P, Tang P, Hasan M, Yassine H, et al.
Influenza Other Respir Viruses
. 2024 Sep;
18(10):e13357.
PMID: 39343986
Background: This study provides a head-to-head comparison of the protection provided by the BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 infection and against severe COVID-19, covering primary series and third dose/booster...